Etkin Amit
SEC insider (Form 3/4/5 filer). CIK 0002007795. PRESIDENT AND CEO at Alto Neuroscience, Inc. (ANRO). 12 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in MOUTAIN VIEW, CA.
Companies Etkin Amit has filed insider reports for
- Alto Neuroscience, Inc. (ANRO): Director, Officer, PRESIDENT AND CEO
Etkin Amit
CIK: 0002007795
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Alto Neuroscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- May 14, 2026ANRO
Alto Neuroscience, Inc.
GiftDirect400K shares- - Mar 1, 2026ANRO
Alto Neuroscience, Inc.
Tax PaymentDirect6.2K shares at avg. $19.69$123K - Feb 11, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
306K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
247.3K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
223K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
223K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
215K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
215K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
247.3K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
34.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | ANRO Alto Neuroscience, Inc. | Gift | 400,000 | - | $0 | Direct |
| Mar 1, 2026 | ANRO Alto Neuroscience, Inc. | Tax Payment | 6,227 | $19.69 | $122,610 | Direct |
| Feb 11, 2026 | ANRO Alto Neuroscience, Inc. | Award Employee Stock Option (Right to Buy) | 306,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award Employee Stock Option (Right to Buy) | 247,290 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award Employee Stock Option (Right to Buy) | 223,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition Employee Stock Option (Right to Buy) | 223,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award Employee Stock Option (Right to Buy) | 215,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition Employee Stock Option (Right to Buy) | 215,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition Employee Stock Option (Right to Buy) | 247,290 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award Employee Stock Option (Right to Buy) | 34,620 | - | - | Direct |
1-10 of 12 transactions